Targeted salivary biomarkers for discrimination of periodontal health and disease(s)

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue AUG, 2015, Pages

  Ebersole, Jeffrey L ^a   Nagarajan, Radhakrishnan ^b   Akers, David ^c   Miller, Craig S ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cytokines; MMP 8; Periodontitis; Personalized medicine; Saliva

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTROPHIL COLLAGENASE; CYTOKINE;

ADULT; ARTICLE; FEMALE; GINGIVITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MOUTH EXAMINATION; PERIODONTAL DISEASE; PERIODONTITIS; RECEIVER OPERATING CHARACTERISTIC; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; CHEMISTRY; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; SALIVA; YOUNG ADULT;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; PERIODONTITIS; SALIVA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 85006213935     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2015.00062     Document Type: Article

References (93)

1. Albandar, J. M., Kingman, A., Brown, L. J., and Löe, H. (1998). Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis. J. Clin. Periodontol. 25, 231-237. doi: 10.1111/j.1600-051X.1998.tb02433.x.
2. Al-Sabbagh, M., Alladah, A., Lin, Y., Kryscio, R. J., Thomas, M. V., Ebersole, J. L., et al. (2012). Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. J. Periodont. Res. 47, 389-395. doi: 10.1111/j.1600-0765.2011.01445.x.
3. Armitage, G. C., and Cullinan, M. P. (2010). Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol. 2000 53, 12-27. doi: 10.1111/j.1600-0757.2010.00353.x.
4. Armitage, G. C., and Robertson, P. B. (2009). The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States. J. Am. Dent. Assoc. 140(Suppl. 1), 36S-43S. doi: 10.14219/jada.archive.2009.0356.
5. Armitage, G. C., Svanberg, G. K., and Löe, H. (1977). Microscopic evaluation of clinical measurements of connective tissue attachment levels. J. Clin. Periodontol. 4, 173-190. doi: 10.1111/j.1600-051X.1977.tb02271.x.
6. Baker, S. G. (2003). The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J. Natl. Cancer Inst. 95, 511-515. doi: 10.1093/jnci/95.7.511.
7. Beikler, T., Peters, U., Prior, K., Eisenacher, M., and Flemmig, T. F. (2008). Gene expression in periodontal tissues following treatment. BMC Med. Genomics 1:30. doi: 10.1186/1755-8794-1-30.
8. Braun, T., and Schett, G. (2012). Pathways for bone loss in inflammatory disease. Curr. Osteoporos. Rep. 10, 101-108. doi: 10.1007/s11914-012-0104-5.
9. Brecx, M. C., Nalbandian, J., Kornman, K. S., and Robertson, P. B. (1986). Morphological studies on periodontal disease in the cynomolgus monkey. III. Electron microscopic observations. J. Periodont. Res. 21, 137-153. doi: 10.1111/j.1600-0765.1986.tb01446.x.
10. Cierny, J. T., Unal, E. R., Flood, P., Rhee, K. Y., Praktish, A., Olson, T. H., et al. (2014). Maternal inflammatory markers and term labor performance. Am. J. Obstet. Gynecol. 210, 447.e1-6. doi: 10.1016/j.ajog.2013.11.038.
11. Costa, P. P., Trevisan, G. L., Macedo, G. O., Palioto, D. B., Souza, S. L., Grisi, M. F., et al. (2010). Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J. Periodontol. 81, 384-391. doi: 10.1902/jop.2009.090510.
12. de Lima Oliveira, A. P., de Faveri, M., Gursky, L. C., Mestnik, M. J., Feres, M., Haffajee, A. D., et al. (2012). Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J. Clin. Periodontol. 39, 295-302. doi: 10.1111/j.1600-051X.2011.01817.x.
13. Desai, G. S., and Mathews, S. T. (2014). Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J. Diabetes 5, 730-738. doi: 10.4239/wjd.v5.i6.730.
14. Diehl, S. R., Kuo, F., and Hart, T. C. (2015). Interleukin 1 genetic tests provide no support for reduction of preventive dental care. J. Am. Dent. Assoc. 146, 164-173.e4. doi: 10.1016/j.adaj.2014.12.018.
15. Duarte, P. M., Miranda, T. S., Lima, J. A., Dias Goncalves, T. E., Santos, V. R., Bastos, M. F., et al. (2012). Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. J. Periodontol. 83, 426-434. doi: 10.1902/jop.2011.110324.
16. Ebersole, J. L., Dawson, D. R. III, Morford, L. A., Peyyala, R., Miller, C. S., and Gonzaléz, O. A. (2013). Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontol. 2000 62, 163-202. doi: 10.1111/prd.12005.
17. Fain, J. N. (2006). Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74, 443-477. doi: 10.1016/S0083-6729(06)74018-3.
18. Faizuddin, M., Bharathi, S. H., and Rohini, N. V. (2003). Estimation of interleukin-1β levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J. Periodont. Res. 38, 111-114. doi: 10.1034/j.1600-0765.2003.01649.x.
19. Fine, D. H., Markowitz, K., Furgang, D., Fairlie, K., Ferrandiz, J., Nasri, C., et al. (2009). Macrophage inflammatory protein-1α: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J. Periodontol. 80, 106-113. doi: 10.1902/jop.2009.080296.
20. Flores, M., Glusman, G., Brogaard, K., Price, N. D., and Hood, L. (2013). P4 medicine: how systems medicine will transform the healthcare sector and society. Per. Med. 10, 565-576. doi: 10.2217/pme.13.57.
21. Frodge, B. D., Ebersole, J. L., Kryscio, R. J., Thomas, M. V., and Miller, C. S. (2008). Bone remodeling biomarkers of periodontal disease in saliva. J. Periodontol. 79, 1913-1919. doi: 10.1902/jop.2008.080070.
22. Fujita, Y., Ito, H., Sekino, S., and Numabe, Y. (2012). Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology 100, 215-221. doi: 10.1007/s10266-011-0042-1.
23. Giannobile, W. V., Beikler, T., Kinney, J. S., Ramseier, C. A., Morelli, T., and Wong, D. T. (2009). Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol. 2000 50, 52-64. doi: 10.1111/j.1600-0757.2008.00288.x.
24. Giuliani, N., Colla, S., and Rizzoli, V. (2004). New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL). Exp. Hematol. 32, 685-691. doi: 10.1016/j.exphem.2004.03.015.
25. Glass, W. G., Rosenberg, H. F., and Murphy, P. M. (2003). Chemokine regulation of inflammation during acute viral infection. Curr. Opin. Allergy Clin. Immunol. 3, 467-473. doi: 10.1097/00130832-200312000-00008.
26. Grigoriadou, M. E., Koutayas, S. O., Madianos, P. N., and Strub, J. R. (2010). Interleukin-1 as a genetic marker for periodontitis: review of the literature. Quintessence Int. (Berl.) 41, 517-525.
27. Gümüs, P., Nizam, N., Lappin, D. F., and Buduneli, N. (2014). Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis. J. Periodontol. 85, 270-280. doi: 10.1902/jop.2013.130117.
28. Gursoy, U. K., Könönen, E., Uitto, V. J., Pussinen, P. J., Hyvärinen, K., Suominen-Taipale, L., et al. (2009). Salivary interleukin-1β concentration and the presence of multiple pathogens in periodontitis. J. Clin. Periodontol. 36, 922-927. doi: 10.1111/j.1600-051X.2009.01480.x.
29. Hajishengallis, G. (2014). The inflammophilic character of the periodontitis-associated microbiota. Mol. Oral Microbiol. 29, 248-257. doi: 10.1111/omi.12065.
30. Henskens, Y. M., van der Velden, U., Veerman, E. C., and Nieuw Amerongen, A. V. (1993). Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J. Periodont. Res. 28, 43-48. doi: 10.1111/j.1600-0765.1993.tb01049.x.
31. Hood, L., Balling, R., and Auffray, C. (2012). Revolutionizing medicine in the 21st century through systems approaches. Biotechnol. J. 7, 992-1001. doi: 10.1002/biot.201100306.
32. Huang, G. T., Do, M., Wingard, M., Park, J. S., and Chugal, N. (2001). Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 92, 83-88. doi: 10.1067/moe.2001.115025.
33. Javed, F., Ahmed, H. B., Saeed, A., Mehmood, A., and Bain, C. (2014). Whole salivary interleukin-6 and matrix metalloproteinase-8 levels in patients with chronic periodontitis with and without prediabetes. J. Periodontol. 85, e130-e135. doi: 10.1902/jop.2013.130514.
34. Javed, F., Al-Askar, M., and Al-Hezaimi, K. (2012). Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review. J. Periodontol. 83, 156-161. doi: 10.1902/jop.2011.110207.
35. Jönsson, D., Ramberg, P., Demmer, R. T., Kebschull, M., Dahlén, G., and Papapanou, P. N. (2011). Gingival tissue transcriptomes in experimental gingivitis. J. Clin. Periodontol. 38, 599-611. doi: 10.1111/j.1600-051X.2011.01719.x.
36. Kabashima, H., Yoneda, M., Nagata, K., Hirofuji, T., and Maeda, K. (2002). The presence of chemokine (MCP-1, MIP-1α, MIP-1β, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20, 70-77. doi: 10.1006/cyto.2002.1985.
37. Kabashima, H., Yoneda, M., Nagata, K., Hirofuji, T., Ishihara, Y., Yamashita, M., et al. (2001). The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1α, MIP-1β, IP-10)-positive cells in human periapical granulomas. Cytokine 16, 62-66. doi: 10.1006/cyto.2001.0947.
38. Kardesler, L., Buduneli, N., Cetinkalp, S., Lappin, D., and Kinane, D. F. (2011). Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes. Inflamm. Res. 60, 143-151. doi: 10.1007/s00011-010-0248-7.
39. Kaushik, R., Yeltiwar, R. K., and Pushpanshu, K. (2011). Salivary Interleukin-1β levels in chronic periodontitis patients before and after periodontal phase I therapy and healthy controls: a case-control study. J. Periodontol. 82, 1353-1359. doi: 10.1902/jop.2011.100472.
40. Kebschull, M., Demmer, R. T., Grün, B., Guarnieri, P., Pavlidis, P., and Papapanou, P. N. (2014). Gingival tissue transcriptomes identify distinct periodontitis phenotypes. J. Dent. Res. 93, 459-468. doi: 10.1177/0022034514527288.
41. Kebschull, M., Guarnieri, P., Demmer, R. T., Boulesteix, A. L., Pavlidis, P., and Papapanou, P. N. (2013). Molecular differences between chronic and aggressive periodontitis. J. Dent. Res. 92, 1081-1088. doi: 10.1177/0022034513506011.
42. Kim, D. M., Ramoni, M. F., Nevins, M., and Fiorellini, J. P. (2006). The gene expression profile in refractory periodontitis patients. J. Periodontol. 77, 1043-1050. doi: 10.1902/jop.2006.050254.
43. Kinane, D. F., Darby, I. B., Said, S., Luoto, H., Sorsa, T., Tikanoja, S., et al. (2003). Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J. Periodont. Res. 38, 400-404. doi: 10.1034/j.1600-0765.2003.00663.x.
44. Kinney, J. S., Morelli, T., Braun, T., Ramseier, C. A., Herr, A. E., Sugai, J. V., et al. (2011). Saliva/pathogen biomarker signatures and periodontal disease progression. J. Dent. Res. 90, 752-758. doi: 10.1177/0022034511399908.
45. Kinney, J. S., Morelli, T., Oh, M., Braun, T. M., Ramseier, C. A., Sugai, J. V., et al. (2014). Crevicular fluid biomarkers and periodontal disease progression. J. Clin. Periodontol. 41, 113-120. doi: 10.1111/jcpe.12194.
46. Kornman, K. S., Page, R. C., and Tonetti, M. S. (1997). The host response to the microbial challenge in periodontitis: assembling the players. Periodontol. 2000 14, 33-53. doi: 10.1111/j.1600-0757.1997.tb00191.x.
47. Lang, N. P., Schatzle, M. A., and Loe, H. (2009). Gingivitis as a risk factor in periodontal disease. J. Clin. Periodontol. 36, 3-8. doi: 10.1111/j.1600-051X.2009.01415.x.
48. Lang, N. P., Tonetti, M. S., Suter, J., Sorrell, J., Duff, G. W., and Kornman, K. S. (2000). Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J. Periodontal Res. 35, 102-107. doi: 10.1034/j.1600-0765.2000.035002102.x.
49. Lee, A., Ghaname, C. B., Braun, T. M., Sugai, J. V., Teles, R. P., Loesche, W. J., et al. (2012). Bacterial and salivary biomarkers predict the gingival inflammatory profile. J. Periodontol. 83, 79-89. doi: 10.1902/jop.2011.110060.
50. Leishman, S. J., Seymour, G. J., and Ford, P. J. (2013). Local and systemic inflammatory responses to experimentally induced gingivitis. Dis. Markers 35, 543-549. doi: 10.1155/2013/948569.
51. Lewis, J. G. (2006). Steroid analysis in saliva: an overview. Clin. Biochem. Rev. 27, 139-146.
52. Mäntylä, P., Stenman, M., Kinane, D., Salo, T., Suomalainen, K., Tikanoja, S., et al. (2006). Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J. Periodont. Res. 41, 503-512. doi: 10.1111/j.1600-0765.2006.00897.x.
53. Miller, C. S., Foley, J. D. III, Floriano, P. N., Christodoulides, N., Ebersole, J. L., Campbell, C. L., et al. (2014). Utility of salivary biomarkers for demonstrating acute myocardial infarction. J. Dent. Res. 93(7 Suppl.), 72S-79S. doi: 10.1177/0022034514537522.
54. Miller, C. S., Foley, J. D., Bailey, A. L., Campbell, C. L., Humphries, R. L., Christodoulides, N., et al. (2010). Current developments in salivary diagnostics. Biomark. Med. 4, 1-18. doi: 10.2217/bmm.09.68.
55. Miller, C. S., King, C. P. Jr., Langub, M. C., Kryscio, R. J., and Thomas, M. V. (2006). Salivary biomarkers of existing periodontal disease: a cross-sectional study. J. Am. Dent. Assoc. 137, 322-329. doi: 10.14219/jada.archive.2006.0181.
56. Mirnezami, R., Nicholson, J., and Darzi, A. (2012). Preparing for precision medicine. N. Engl. J. Med. 366, 489-491. doi: 10.1056/NEJMp1114866.
57. Mirrielees, J., Crofford, L. J., Lin, Y., Kryscio, R. J., Dawson, D. R. III, Ebersole, J. L., et al. (2010). Rheumatoid arthritis and salivary biomarkers of periodontal disease. J. Clin. Periodontol. 37, 1068-1074. doi: 10.1111/j.1600-051X.2010.01625.x.
58. Moore, C., and Crouch, D. (2013). Oral fluid for the detection of drugs of abuse using immunoassay and LC-MS/MS. Bioanalysis 5, 1555-1569. doi: 10.4155/bio.13.115.
59. Nakashima, T., and Takayanagi, H. (2009). Osteoimmunology: crosstalk between the immune and bone systems. J. Clin. Immunol. 29, 555-567. doi: 10.1007/s10875-009-9316-6.
60. Navazesh, M. (1993). Methods for collecting saliva. Ann. N.Y. Acad. Sci. 694, 72-77. doi: 10.1111/j.1749-6632.1993.tb18343.x.
61. Nibali, L., Henderson, B., Sadiq, S. T., and Donos, N. (2014). Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J. Oral Microbiol. 6. doi: 10.3402/jom.v6.22962.
62. Offenbacher, S., Barros, S. P., Paquette, D. W., Winston, J. L., Biesbrock, A. R., Thomason, R. G., et al. (2009). Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J. Periodontol. 80, 1963-1982. doi: 10.1902/jop.2009.080645.
63. Offenbacher, S., Barros, S., Mendoza, L., Mauriello, S., Preisser, J., Moss, K., et al. (2010). Changes in gingival crevicular fluid inflammatory mediator levels during the induction and resolution of experimental gingivitis in humans. J. Clin. Periodontol. 37, 324-333. doi: 10.1111/j.1600-051X.2010.01543.x.
64. Page, R. C. (1986). Gingivitis. J. Clin. Periodontol. 13, 345-359. doi: 10.1111/j.1600-051X.1986.tb01471.x.
65. Page, R. C., and Schroeder, H. E. (1976). Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab. Invest. 34, 235-249.
66. Pant Pai, N., Balram, B., Shivkumar, S., Martinez-Cajas, J. L., Claessens, C., Lambert, G., et al. (2012). Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect. Dis. 12, 373-380. doi: 10.1016/S1473-3099(11)70368-1.
67. Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., et al. (2001). Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 93, 1054-1061. doi: 10.1093/jnci/93.14.1054.
68. Prakasam, S., and Srinivasan, M. (2014). Evaluation of salivary biomarker profiles following non-surgical management of chronic periodontitis. Oral Dis. 20, 171-177. doi: 10.1111/odi.12085.
69. Rabinowitz, K., and Mayer, L. (2012). Working out mechanisms of controlled/physiologic inflammation in the GI tract. Immunol. Res. 54, 14-24. doi: 10.1007/s12026-012-8315-5.
70. Salminen, A., Gursoy, U. K., Paju, S., Hyvärinen, K., Mäntylä, P., Buhlin, K., et al. (2014). Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J. Clin. Periodontol. 41, 442-450. doi: 10.1111/jcpe.12234.
71. Schätzle, M., Faddy, M. J., Cullinan, M. P., Seymour, G. J., Lang, N. P., Bürgin, W., et al. (2009). The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease. J. Clin. Periodontol. 36, 365-371. doi: 10.1111/j.1600-051X.2009.01391.x.
72. Schätzle, M., Löe, H., Burgin, W., Anerud, A., Boysen, H., and Lang, N. P. (2003). Clinical course of chronic periodontitis. I. Role of gingivitis. J. Clin. Periodontol. 30, 887-901. doi: 10.1034/j.1600-051X.2003.00414.x.
73. Schätzle, M., Löe, H., Lang, N. P., Bürgin, W., Anerud, A., and Boysen, H. (2004). The clinical course of chronic periodontitis. J. Clin. Periodontol. 31, 1122-1127. doi: 10.1111/j.1600-051X.2004.00634.x.
74. Scheidweiler, K. B., Marrone, G. F., Shakleya, D. M., Singleton, E. G., Heishman, S. J., and Huestis, M. A. (2011). Oral fluid nicotine markers to assess smoking status and recency of use. Ther. Drug Monit. 33, 609-618. doi: 10.1097/ftd.0b013e318228ba39.
75. Schmidt, C. (2014). Leroy Hood looks forward to P4 medicine: predictive, personalized, preventive, and participatory. J. Natl. Cancer Inst. 106:dju416. doi: 10.1093/jnci/dju416.
76. Sexton, W. M., Lin, Y., Kryscio, R. J., Dawson, D. R. III, Ebersole, J. L., and Miller, C. S. (2011). Salivary biomarkers of periodontal disease in response to treatment. J. Clin. Periodontol. 38, 434-441. doi: 10.1111/j.1600-051X.2011.01706.x.
77. Shaila, M., Pai, G. P., and Shetty, P. (2013). Salivary protein concentration, flow rate, buffer capacity and pH estimation: a comparative study among young and elderly subjects, both normal and with gingivitis and periodontitis. J. Indian Soc. Periodontol. 17, 42-46. doi: 10.4103/0972-124X.107473.
78. Silva, T. A., Garlet, G. P., Fukada, S. Y., Silva, J. S., and Cunha, F. Q. (2007). Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J. Dent. Res. 86, 306-319. doi: 10.1177/154405910708600403.
79. Song, G. G., Choi, S. J., Ji, J. D., and Lee, Y. H. (2013). Association between tumor necrosis factor-α promoter-308 A/G,-238 A/G, interleukin-6-174 G/C and-572 G/C polymorphisms and periodontal disease: a meta-analysis. Mol. Biol. Rep. 40, 5191-5203. doi: 10.1007/s11033-013-2621-4.
80. Sorsa, T., Mantyla, P., Ronka, H., Kallio, P., Kallis, G. B., Lundqvist, C., et al. (1999). Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann. N.Y. Acad. Sci. 878, 130-140. doi: 10.1111/j.1749-6632.1999.tb07679.x.
81. Swift, R. (2003). Direct measurement of alcohol and its metabolites. Addiction 98, 73-80. doi: 10.1046/j.1359-6357.2003.00605.x.
82. Syndergaard, B., Al-Sabbagh, M., Kryscio, R. J., Xi, J., Ding, X., Ebersole, J. L., et al. (2014). Salivary biomarkers associated with gingivitis and response to therapy. J. Periodontol. 85, e295-e303. doi: 10.1902/jop.2014.130696.
83. Terpos, E., Politou, M., Viniou, N., and Rahemtulla, A. (2005). Significance of macrophage inflammatory protein-1 α (MIP-1α) in multiple myeloma. Leuk. Lymphoma 46, 1699-1707. doi: 10.1080/10428190500175049.
84. Tervahartiala, T., Pirilä, E., Ceponis, A., Maisi, P., Salo, T., Tuter, G., et al. (2000). The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2,-8,-13, and-14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J. Dent. Res. 79, 1969-1977. doi: 10.1177/00220345000790120801.
85. Thomas, M. V., Branscum, A., Miller, C. S., Ebersole, J., Al-Sabbagh, M., and Schuster, J. L. (2009). Within-subject variability in repeated measures of salivary analytes in healthy adults. J. Periodontol. 80, 1146-1153. doi: 10.1902/jop.2009.080654.
86. Tobón-Arroyave, S. I., Jaramillo-González, P. E., and Isaza-Guzmán, D. M. (2008). Correlation between salivary IL-1β levels and periodontal clinical status. Arch. Oral Biol. 53, 346-352. doi: 10.1016/j.archoralbio.2007.11.005.
87. Trombelli, L. (2004). Susceptibility to gingivitis: a way to predict periodontal disease? Oral Health Prev. Dent. 2(Suppl. 1), 265-269.
88. van Andel, H. W., Jansen, L. M., Grietens, H., Knorth, E. J., and van der Gaag, R. J. (2014). Salivary cortisol: a possible biomarker in evaluating stress and effects of interventions in young foster children? Eur. Child Adolesc. Psychiatry 23, 3-12. doi: 10.1007/s00787-013-0439-1.
89. Van Dyke, T. E., and Sheilesh, D. (2005). Risk factors for periodontitis. J. Int. Acad. Periodontol. 7, 3-7.
90. Wu, T., Sajitharan, D., and Mohan, C. (2010). Biomarkers of rheumatoid arthritis: recent progress. Expert Opin. Med. Diagn. 4, 293-305. doi: 10.1517/17530059.2010.492828.
91. Yoon, A. J., Cheng, B., Philipone, E., Turner, R., and Lamster, I. B. (2012). Inflammatory biomarkers in saliva: assessing the strength of association of diabetes mellitus and periodontal status with the oral inflammatory burden. J. Clin. Periodontol. 39, 434-440. doi: 10.1111/j.1600-051X.2012.01866.x.
92. Yucel-Lindberg, T., and Båge, T. (2013). Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev. Mol. Med. 15:e7. doi: 10.1017/erm.2013.8.
93. Zakynthinos, E., and Pappa, N. (2009). Inflammatory biomarkers in coronary artery disease. J. Cardiol. 53, 317-333. doi: 10.1016/j.jjcc.2008.12.007.